Independent doctors who work on the front line, face to face with sick patients, have searched the books and their knowledge for solutions to help treat their patients with COVID-19 symptoms.
Repurposing known, cheap, off-patent drugs, singularly or in combinations, has been much of their focus. Drugs with already know side-effect and toxicity profiles. Drugs that are cheap, because the are off-patent, and have no “commercial value”. Drugs that when they tried them, have literally been life saving and prevented the need for tens of thousands of hospitalisations, which was the whole purpose of the March 2020 global lockdowns – flatten the curve!
Health authorities designed clinical trials to assess the “potential” of therapeutics in hospitalised patients only, they used doses that exceeded known toxic levels, and they didn’t do combination drug therapies! At least this is true for HCQ in the first 9 months of the pandemic.
Later in the pandemic, they carried out a few outpatient treatment trials again not in combination, just single drugs. Though the Oxford randomised budesonide study they had to cut short, because the treatment was so successful, they couldn’t ethically keep it from the control group. The same is true for ivermectin.
Early treatments have been largely ignored, why?
Early treatment options have seemingly been ignored by the “health authorities”, and poorly challenged by the main stream media. There has been a strong push from the start of the pandemic that a vaccine will be the only solution!
The information about early treatment options is available, you just need to know where to look as it has been suppressed by Big Tech and the media. Unknown “fact checkers” deemed it dis-information. Judge for yourself. Take the time to investigate yourself.
December 17, 2020 – Leon Klein: AFFORDABLE AND EFFECTIVE EARLY TREATMENTS – A summary overview – WATCH
Multidrug-therapy for high-risk patients has resulted in 85% reductions in COVID-19 hospitalization and death*.
*McCullough PA, Alexander PE, Armstrong R, et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med (2020) 21:517–530. doi:10.31083/j.rcm.2020.04.264. Link to paper here.
Treatment resources
There are many websites that are aggregating trial results, protocols and testimony from front line doctors and scientific specialists. As we find these links we’ll add them to this page.
The Science data – C19 early – COVID-19 early treatment: real-time analysis – HERE
COVID-19 Protocols:
C19 Protocols website contains links to:
- Early Treatment Protocols,
- Prevention Protocols,
- Long-haul COVID-19 Protocols,
- Scientific studies and more
The above site is complied by front line doctors, those who are actually treating patients.
Early COVID Care – HERE,
FLCCC i-CARE early treatment protocols – HERE
WHO: Therapeutics and COVID-19: living guideline – April 2022 – ARCHIVE
Treatment Summaries
- Multi-drug approach – video and paper
- Budesonide
- Hydroxychloroquine
- Ivermectin
- Vitamin C and video and link and resource
- Vitamin D
- CDS , Preparation, Clinical trial here Published here
Studies demonstrating the efficacy of COVID-19 treatments – Evidence by drug group @ early COVID care – HERE
Protocols Links
In no particular order
America’s Frontline Doctors – videos
Medicine (un)censored by James Todaro MD
COVID-19 How can I cure thee? Let me count the ways by Dr Thomas Levy
Official treatment guidelines
May 27, 2020 – WHO Intrim Guidance: Clinical management of COVID-19 – READ, ARCHIVES
Other Treatment Options
2023
July 29, 2023 – Courageous Discourse Substack: The Clear Benefits of Nasal Hygiene an interview with Mr. Nathan Jones, CEO of XLEAR nasal spray – WATCH & READ
- “Decades ago, Nate’s father, Dr. Alonzo Jones, began an exhaustive study of the benefits of oral and nasal hygiene for preventing upper respiratory tract infections. Nate found his father’s research so compelling that he formulated a nasal spray based on Dr. Jones’s findings”
- “…multiple lab tests confirmed that a minor component of XLEAR nasal spray—i.e., its grapefruit seed extract preservative—destroys SARS-CoV-2“
- “…the Federal Trade Commission prohibited every company in the nasal hygiene space from making any claims about the benefit of their products in preventing SARS-CoV-2 infection, reducing its severity, or reducing its transmissibility.”…”in spite of numerous peer-reviewed studies in the medical literature showing that viricidal nasal rinses can indeed reduce the duration and severity of the illness” – inorder to get EUA on mRNA jabs!
- FTC sued XLEAR in court – READ, the fight is ongoing.
July 27, 2023 – Meryl Nass Substack: Treating COVID-19 in 2023 and update ivermecting and hydroxychloroquine – READ, i-CARE protocols – HERE
2022
August 2, 2022 – Journal of Pharmacy & Pharmacology Research: The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure? – Fazio et al – READ, PDF
Working group concluded there was obstruction to home-based therapies for COVID-19. – GETTR
July 20, 2022 – Dr Paul Alexander Substack: Nitric Oxide Nasal Spray (NONS) lowers Covid viral load by 94 per cent in 24 hours: Lancet study; Nitric Oxide blocks entry into nasal passage, kills the virus and stops its replication – READ
April 22, 2022 – WHO: Therapeutics and COVID-19: living guideline – ARCHIVE, Gilead press release – READ
- Early treatment with remdesivir recommended but at no time should hydroxychloroquine be used.
April 14, 2022 – Steve Kirsch Substack: These people deserve the credit for the deaths of nearly a million Americans – Introducing the members of the NIH COVID-19 Treatment Guidelines committee. – “if there are 100 trials and 90% of the trials were positive and 10% were neutral, should the NIH recommend the drug?” – READ
2020
December 30, 2020 – Reviews in Cardiovascular Medicine: Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) by McCullough et al – ARCHIVE, READ
October 11, 2020 – Association of American Physicians and Surgeons: Ambulatory Treatment of COVID-19 – WATCH, PAPER, SLIDES
August 26, 2020 – The Texan: Dallas Cardiologist Offers Guidance on Early Treatment of COVID-19 – To provide guidance to doctors about early treatment of coronavirus, cardiologist Dr. Peter McCullough wrote an article that will soon be published in the American Journal of Medicine – READ, Dr Peter McCullough – MORE
March 17, 2020 – International Society for Orthomolecular Medicine (ISOM) recommends nutrition support for curing and treating new coronavirus infections – WATCH, READ
